Potentiality of Q3 characterization of nanosystem: Surrogate data for obtaining a biowaiver (Q98281653)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32770572 AND SRC:MED&resulttype=core&format=json

12 August 2020

title

Potentiality of Q3 characterization of nanosystem: Surrogate data for obtaining a biowaiver (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32770572 AND SRC:MED&resulttype=core&format=json

12 August 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32770572 AND SRC:MED&resulttype=core&format=json

12 August 2020

author name string

Vignesh Mohan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32770572 AND SRC:MED&resulttype=core&format=json

12 August 2020

publication date

7 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32770572 AND SRC:MED&resulttype=core&format=json

Drug Development Research

12 August 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32770572 AND SRC:MED&resulttype=core&format=json

Freeze-drying of nanoparticles: formulation, process and storage considerations

12 August 2020

cites work

1 reference

7 January 2021

Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities

1 reference

7 January 2021

Generic development of topical dermatologic products: formulation development, process development, and testing of topical dermatologic products

1 reference

7 January 2021

Medical Aerosol Inhalers: Past, Present, and Future

1 reference

7 January 2021

Impact of Biopharmaceutics Classification System-based biowaivers

1 reference

7 January 2021

Challenges in Development of Nanoparticle-Based Therapeutics

1 reference

7 January 2021

A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study.

1 reference

7 January 2021

Active matter therapeutics

1 reference

7 January 2021

Size, Stability, and Porosity of Mesoporous Nanoparticles Characterized with Light Scattering.

1 reference

7 January 2021

From drug delivery systems to drug release, dissolution, IVIVC, BCS, BDDCS, bioequivalence and biowaivers

1 reference

7 January 2021

WHO standards for biotherapeutics, including biosimilars: an example of the evaluation of complex biological products

1 reference

7 January 2021

Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation

1 reference

7 January 2021

Nanosystem trends in drug delivery using quality-by-design concept.

1 reference

7 January 2021

Improved Dynamic Light Scattering using an adaptive and statistically driven time resolved treatment of correlation data

1 reference

7 January 2021

Regulatory challenges of nanomedicines and their follow-on versions: A generic or similar approach?

1 reference

7 January 2021

Regulatory challenges and approaches to characterize nanomedicines and their follow-on similars

1 reference

7 January 2021

Controlled drug delivery systems: past forward and future back

1 reference

7 January 2021

Drug delivery of the future: Chasing the invisible gorilla

1 reference

7 January 2021

Transdermal patches: history, development and pharmacology.

1 reference

7 January 2021

Nano based drug delivery systems: recent developments and future prospects

1 reference

7 January 2021

Nanosuspensions in drug delivery

1 reference

7 January 2021

Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures

1 reference

7 January 2021

Accelerated in-vitro release testing methods for extended-release parenteral dosage forms

1 reference

7 January 2021

In vitro-in vivo correlation for complex non-oral drug products: Where do we stand?

1 reference

7 January 2021

Nanomedicine: Principles, Properties, and Regulatory Issues

1 reference

7 January 2021

Impact of uncharged and charged stabilizers on in vitro drug performances of clarithromycin nanocrystals

1 reference

7 January 2021

Applications of nanoparticles in treatment and diagnosis of leukemia.

1 reference

7 January 2021

Nanogels as potential nanomedicine carrier for treatment of cancer: A mini review of the state of the art

1 reference

7 January 2021

The importance of nanoparticle shape in cancer drug delivery.

1 reference

7 January 2021

Nanopharmaceuticals (part 1): products on the market

1 reference

7 January 2021

Anticancer Drug-Loaded Nanospheres Based on Biodegradable Amphiphilic ε-Caprolactone and Carbonate Copolymers

1 reference

7 January 2021

Controlled Drug Delivery: Historical perspective for the next generation

1 reference

7 January 2021

Influence of nanoparticle shapes on cellular uptake of paclitaxel loaded nanoparticles in 2D and 3D cancer models

1 reference

7 January 2021

A Comprehensive Map of FDA-Approved Pharmaceutical Products

1 reference

7 January 2021

Identifiers

DOI

10.1002/DDR.21731

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32770572 AND SRC:MED&resulttype=core&format=json

12 August 2020

1 reference